PharmaBoardroom

Interview with Mark Glover , Vice President and Managing…

How have PBS reforms impacted Allergan in Australia? The PBS is a very good system that provides Australians with equity of access and has worked well…

Interview with John Montgomery , CEO, Alphapharm

Alphapharm recently celebrated its 25th anniversary. In light of this significant milestone, would you give us a brief introduction to the company?…

Interview with Jez Moulding, General Manager, Sanofi Australia

What impact have the PBS reforms had on sanofi-aventis in Australia? Sanofi-aventis has one of the largest portfolios of medicines in Australia,…

Interview with Joyce Lloyd and Munro Neville, Managing Director,…

Would you please introduce Pretium’s specific service offerings, and the focus within these? Pretium offers a comprehensive range of integrated…

Interview with Andrew Carter, Managing Director, Commercial Eyes

What are some of the challenges facing pharmaceutical companies in Australia today? There are four major challenges within the Australian…

Interview with Ralf Dahmen, Managing Director, Galderma

As ASMI President and Managing Director of Galderma, would you please give us a brief overview of the Australian OTC market and Galderma’s role…

Interview with Richard Davies, Managing Director, Amgen Australia

What impact have the PBS reforms had on Amgen in Australia? From a company perspective, biotechnology companies exist in a competitive space. They…

Interview with Alek Safarian , Managing Director, Novotech…

One of the hot topics in the industry is the impact of PBS reforms. Can you speak to recent influence of PBS reforms affecting Novotech’s…

Interview with Rob Botha, Vice President UTI Pharma Africa, UTI…

We interviewed Graham Somerville in 2004, the year when IHD, formerly jointly owned by 11 major pharmaceutical companies, was acquired by UTi. We are…

Interview with José Tombazzi, President, Denver Farma

Could you give us an overview of the generics sector in Argentina as it stands at the moment? The generics market in Argentina was started immediately…

Interview with Helen Allars and John Edington, Managing Director…

The Australian pharmaceutical sector has seen recent innovations through PBS reform and various working groups shaping the future of the industry. Can…

Interview with Dan Brown , Managing Director, Genzyme Australia

What impact will the recent PBS reforms have on Genzyme’s operations in Australia? Genzyme is different in terms of its focus on rare &…

Tagged with